BioCentury
ARTICLE | Company News

Parsey returns to Genentech

October 20, 2015 1:27 AM UTC

The Genentech unit of Roche (SIX:ROG; OTCQX:RHHBY) hired Merdad Parsey as SVP of early clinical development. Parsey was Genentech's senior group medical director in its Genentech Research and Early Development unit until 2010. He left the company to become CEO of 3-V Biosciences Inc. (Menlo Park, Calif.), a position he held until recently (see BioCentury Extra, Sept. 30, 2010).

Parsey replaces Sean Bohen, who last month joined AstraZeneca plc (LSE:AZN; NYSE:AZN) as CMO and EVP of global medicines development (see BioCentury Extra, Aug. 24). ...